Zdrowie i gospodarka · 17/10/2024

FDA Announces Temporary Policies for Compounding Certain Parenteral Drug Products Amid Public Health Emergencies

The US Food and Drug Administration (FDA) has released a final guidance on compounding certain parenteral drug products, following the declaration of public health emergencies in several states due to hurricanes, and outlining regulatory priorities for outsourcing facilities and licensed pharmacies.